Abstract
Twenty-seven patients with surgically resected stage II or III malignant melanoma were treated with bacillus Calmette-Guérin (BCG) and followed prospectively to determine whether relapse could be predicted. Peripheral blood mononuclear (lymphocyte plus monocyte) counts (PBM), T and B cell counts, phytohaemagglutinin (PHA) cytotoxicity, PHA transformation, antibody-dependent cell-mediated cytotoxicity (ADCC) and serum immunoglobulin concentrations were studied before and during therapy. Patients ultimately classified as having a poor clinical outcome (inoperable recurrence) were compared with those with a more favourable outcome. Prior to therapy, poor outcome patients had lower PBM and T cell counts but there was some overlap. After three months, these differences were more pronounced. Low PHA cytotoxicity was also associated with poor outcome; again the differences were more apparent at 3 months than prior to therapy. These results suggest that PBM, T cell counts and PHA cytotoxicity may predict poor outcome some months before inoperable recurrence in apparent clinically.
References
Apr 1, 1977·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J BertoglioJ F Dore
May 1, 1976·Cancer·N J Gross, A C Eddie-Quartey
May 1, 1976·Annals of Surgery·W R JewellL J Humphrey
Mar 1, 1975·Clinical Immunology and Immunopathology·C PotvinB Chretien
Mar 13, 1975·Nature·R L Dawkins, P J Zilko
Nov 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A L ClaudyJ Thivolet
Oct 16, 1971·Lancet·M PapamichailE J Holborow
Jun 2, 1973·Lancet·J U GuttermanE M Hersh
Apr 5, 1969·Lancet·G MathéF De Vassal
May 1, 1973·The Journal of Clinical Investigation·J Wybran, H H Fudenberg
Jul 1, 1974·Journal of Immunological Methods·M E Kaplan, C Clark
Jul 1, 1973·Journal of the National Cancer Institute·L ChessM R Mardiney
Mar 1, 1972·Annals of Internal Medicine·A Z BlumingG Kamya
Sep 1, 1970·Cellular Immunology·P Perlmann, H Perlmann
Citations
Sep 8, 2010·Seminars in Oncology·Kendra FeeneyJonathan S Zager
Aug 2, 1983·Biochemistry·J López de CastroJ L Strominger
Oct 1, 1982·Cancer·J M KirkwoodB M Forget
Nov 27, 2018·Journal of Pathology and Translational Medicine·Jiwon KohYoungmee Kwon
Apr 1, 1985·Irish Journal of Medical Science·M C BoothC F McCarthy
Jun 1, 1983·Journal of Surgical Oncology·M J ByrneC D Holman